Adenocarcinoma [clinicaltrials_resource:ea5fef550a910a2c60d30916913b5c31]
Phase I Study of a Monoclonal Antibody for Treatment of Advanced Adenocarcinomas [clinicaltrials:NCT00051675]Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer [clinicaltrials:NCT00054873]Study of MDX-010 in Stage IV Breast Cancer [clinicaltrials:NCT00083278]clinicaltrials:NCT00088413clinicaltrials:NCT00094445Use of Tracking Devices to Locate Abnormalities During Invasive Procedures [clinicaltrials:NCT00102544]ARQ 501 in Combination With Gemcitabine in Subjects With Pancreatic Cancer [clinicaltrials:NCT00102700]clinicaltrials:NCT00106353Trial of Talabostat and Gemcitabine in Patients With Stage IV Adenocarcinoma of the Pancreas [clinicaltrials:NCT00116389]clinicaltrials:NCT00127036A Long Term Safety Study With Atrasentan [clinicaltrials:NCT00127478]Study of Motexafin Gadolinium (MGd) for Second Line Treatment of Non-Small-Cell Lung Cancer [clinicaltrials:NCT00129844]clinicaltrials:NCT00137839Adjuvant Epirubicin/Cytoxan Followed By A Taxane VS. Epirubicin/Taxane As Treatment For Node-Positive Breast Cancer [clinicaltrials:NCT00140075]Clinical and Pharmacokinetic Trial of Intra-Abdominal Irinotecan [clinicaltrials:NCT00183859]Gemcitabine and Pemetrexed in Primary Unknown Adenocarcinoma [clinicaltrials:NCT00191503]Prospective Phase II Randomized Trial of Postoperative Adjuvant Chemotherapy in Patients With High Risk Colon Cancer [clinicaltrials:NCT00201331]clinicaltrials:NCT00201734clinicaltrials:NCT00201838Evaluation of Stereotactic Radiosurgery For Liver Malignancies [clinicaltrials:NCT00230347]Combined Thoracoscopic and Laparoscopic Esophagectomy vs. Hand-assisted Transhiatal Esophagectomy: A Prospective Trial. [clinicaltrials:NCT00247936]Effects Of Lapatinib (GW572016) In Patients With Relapsed Adenocarcinoma Of The Esophagus [clinicaltrials:NCT00259987]Effect of Vitamin D and Calcium on Genes in the Colon [clinicaltrials:NCT00298545]Spect Analysis of Cardiac Perfusion Changes After Whole Breast/Chest Wall Radiation Therapy With Active Breathing Coordinator [clinicaltrials:NCT00321048]Phase I Dose Escalation of Stereotactic Radiosurgical Boost for Locally Advanced Esophageal Cancer [clinicaltrials:NCT00368329]EndoTAG-1 / Gemcitabine Combination Therapy to Treat Locally Advanced and/or Metastatic Adenocarcinoma of the Pancreas [clinicaltrials:NCT00377936]Safety and Efficacy Therapy of Gemcitabine and Erbitux® to R0 or R1 Resected Pancreatic Cancer [clinicaltrials:NCT00395252]Phase II Trial of Sunitinib in BAC or Never-Smokers With Any Lung Adenocarcinoma [clinicaltrials:NCT00430261]Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer [clinicaltrials:NCT00436657]Testing Drug Sensitivity of Ovarian, Fallopian and Primary Peritoneal Adenocarcinomas [clinicaltrials:NCT00443196]Perioperative Cancer Cell Dissemination and Systemic Immune Suppression in Resectable Ductal Pancreatic Adenocarcinoma [clinicaltrials:NCT00495924]Phase I Irinotecan, 5-Fluorouracil and Leucovorin Combination [clinicaltrials:NCT00507091]Identification of Key Blood Molecular Markers for Immunotherapy [clinicaltrials:NCT00507702]clinicaltrials:NCT00548548clinicaltrials:NCT00600821clinicaltrials:NCT00632203clinicaltrials:NCT00661830A Study of Ixabepilone Before Surgery for High-Risk Localized Prostate Cancer [clinicaltrials:NCT00672009]clinicaltrials:NCT00688753The Character of Perfusion Parameters Derived From MDCT Between Adenocarcinoma and Squamous Cell Carcinoma of Lung in the Treatment Course of Radiation Therapy [clinicaltrials:NCT00751543]
condition [clinicaltrials_vocabulary:condition]
A Phase I Study of Recombinant Vaccinia Virus That Expresses Prostate Specific Antigen in Adult Patients With Adenocarcinoma of the Prostate [clinicaltrials:NCT00001382]Laparoscopic Surgery or Standard Surgery in Treating Patients With Endometrial Cancer or Cancer of the Uterus [clinicaltrials:NCT00002706]Phase I-II Study of Fluorouracil in Combination With Phenylbutyrate in Advanced Colorectal Cancer [clinicaltrials:NCT00002796]Surgery With or Without Chemotherapy in Treating Patients With Stage I Non-small Cell Lung Cancer [clinicaltrials:NCT00002852]Paclitaxel, Cisplatin, and Topotecan With or Without Filgrastim in Treating Patients With Newly Diagnosed Stage III or Stage IV Epithelial Ovarian Cancer [clinicaltrials:NCT00002913]Edrecolomab in Treating Patients With Stage II Colon Cancer [clinicaltrials:NCT00002968]Combination Chemotherapy After Surgery in Treating Patients With Cancer of the Esophagus or Stomach [clinicaltrials:NCT00003237]Antineoplaston Therapy in Treating Patients With Colon Cancer [clinicaltrials:NCT00003486]Antineoplaston Therapy in Treating Patients With Cancer of the Esophagus [clinicaltrials:NCT00003487]Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer [clinicaltrials:NCT00003517]clinicaltrials:NCT00003748Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Rectal Cancer [clinicaltrials:NCT00003799]clinicaltrials:NCT00003834Combination Chemotherapy in Treating Patients With Stage III Colon Cancer [clinicaltrials:NCT00003835]Fluorouracil With or Without Eniluracil in Treating Patients With Advanced Colorectal Cancer [clinicaltrials:NCT00003873]Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu [clinicaltrials:NCT00004074]Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer [clinicaltrials:NCT00005036]Vaccine Therapy in Treating Patients With Advanced Adenocarcinoma of the Prostate (Prostate Cancer) [clinicaltrials:NCT00005039]Photodynamic Therapy With Lutetium Texaphyrin in Treating Patients With Locally Recurrent Prostate Cancer [clinicaltrials:NCT00005067]SU5416 and Irinotecan in Treating Patients With Advanced Colorectal Cancer [clinicaltrials:NCT00005818]Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer [clinicaltrials:NCT00005830]Combination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery [clinicaltrials:NCT00005838]Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer [clinicaltrials:NCT00005840]Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer [clinicaltrials:NCT00005970]clinicaltrials:NCT00006011Trastuzumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer [clinicaltrials:NCT00006089]Oxaliplatin, Fluorouracil, and External-Beam Radiation Therapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum [clinicaltrials:NCT00006094]Combination Chemotherapy Plus Bevacizumab in Treating Patients With Metastatic Prostate Cancer [clinicaltrials:NCT00016107]Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia [clinicaltrials:NCT00017004]Ketoconazole With or Without Alendronate Sodium in Treating Patients With Metastatic Prostate Cancer [clinicaltrials:NCT00019695]Docetaxel With or Without Thalidomide in Treating Patients With Metastatic Prostate Cancer [clinicaltrials:NCT00020046]Combination Chemotherapy and Radiation Therapy Plus Surgery in Treating Patients With Advanced Cancer of the Pancreas [clinicaltrials:NCT00020345]Combination Chemotherapy and Radiation Therapy With or Without Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery [clinicaltrials:NCT00020709]Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer [clinicaltrials:NCT00021060]Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Recurrent or Persistent Metastatic Colorectal Cancer [clinicaltrials:NCT00023933]Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously Treated [clinicaltrials:NCT00025337]Thalidomide in Treating Patients With Recurrent or Persistent Endometrial Cancer [clinicaltrials:NCT00025467]Combination Chemotherapy Plus Radiation Therapy With or Without Tipifarnib in Treating Patients With Locally Advanced Pancreatic Cancer [clinicaltrials:NCT00026104]Hepatic Arterial Infusion Plus Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver [clinicaltrials:NCT00026234]Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer [clinicaltrials:NCT00028496]
condition browse [clinicaltrials_vocabulary:condition-browse]
A Phase I Study of Recombinant Vaccinia Virus That Expresses Prostate Specific Antigen in Adult Patients With Adenocarcinoma of the Prostate [clinicaltrials:NCT00001382]Laparoscopic Surgery or Standard Surgery in Treating Patients With Endometrial Cancer or Cancer of the Uterus [clinicaltrials:NCT00002706]Phase I-II Study of Fluorouracil in Combination With Phenylbutyrate in Advanced Colorectal Cancer [clinicaltrials:NCT00002796]Surgery With or Without Chemotherapy in Treating Patients With Stage I Non-small Cell Lung Cancer [clinicaltrials:NCT00002852]Paclitaxel, Cisplatin, and Topotecan With or Without Filgrastim in Treating Patients With Newly Diagnosed Stage III or Stage IV Epithelial Ovarian Cancer [clinicaltrials:NCT00002913]Edrecolomab in Treating Patients With Stage II Colon Cancer [clinicaltrials:NCT00002968]Combination Chemotherapy After Surgery in Treating Patients With Cancer of the Esophagus or Stomach [clinicaltrials:NCT00003237]Antineoplaston Therapy in Treating Patients With Colon Cancer [clinicaltrials:NCT00003486]Antineoplaston Therapy in Treating Patients With Cancer of the Esophagus [clinicaltrials:NCT00003487]Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer [clinicaltrials:NCT00003517]clinicaltrials:NCT00003748Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Rectal Cancer [clinicaltrials:NCT00003799]clinicaltrials:NCT00003834Combination Chemotherapy in Treating Patients With Stage III Colon Cancer [clinicaltrials:NCT00003835]Fluorouracil With or Without Eniluracil in Treating Patients With Advanced Colorectal Cancer [clinicaltrials:NCT00003873]Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu [clinicaltrials:NCT00004074]Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer [clinicaltrials:NCT00005036]Vaccine Therapy in Treating Patients With Advanced Adenocarcinoma of the Prostate (Prostate Cancer) [clinicaltrials:NCT00005039]Photodynamic Therapy With Lutetium Texaphyrin in Treating Patients With Locally Recurrent Prostate Cancer [clinicaltrials:NCT00005067]SU5416 and Irinotecan in Treating Patients With Advanced Colorectal Cancer [clinicaltrials:NCT00005818]Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer [clinicaltrials:NCT00005830]Combination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery [clinicaltrials:NCT00005838]Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer [clinicaltrials:NCT00005840]Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer [clinicaltrials:NCT00005970]clinicaltrials:NCT00006011Trastuzumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer [clinicaltrials:NCT00006089]Oxaliplatin, Fluorouracil, and External-Beam Radiation Therapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum [clinicaltrials:NCT00006094]Combination Chemotherapy Plus Bevacizumab in Treating Patients With Metastatic Prostate Cancer [clinicaltrials:NCT00016107]Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia [clinicaltrials:NCT00017004]Ketoconazole With or Without Alendronate Sodium in Treating Patients With Metastatic Prostate Cancer [clinicaltrials:NCT00019695]Docetaxel With or Without Thalidomide in Treating Patients With Metastatic Prostate Cancer [clinicaltrials:NCT00020046]Combination Chemotherapy and Radiation Therapy Plus Surgery in Treating Patients With Advanced Cancer of the Pancreas [clinicaltrials:NCT00020345]Combination Chemotherapy and Radiation Therapy With or Without Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery [clinicaltrials:NCT00020709]Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer [clinicaltrials:NCT00021060]Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Recurrent or Persistent Metastatic Colorectal Cancer [clinicaltrials:NCT00023933]Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously Treated [clinicaltrials:NCT00025337]Thalidomide in Treating Patients With Recurrent or Persistent Endometrial Cancer [clinicaltrials:NCT00025467]Combination Chemotherapy Plus Radiation Therapy With or Without Tipifarnib in Treating Patients With Locally Advanced Pancreatic Cancer [clinicaltrials:NCT00026104]Hepatic Arterial Infusion Plus Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver [clinicaltrials:NCT00026234]Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer [clinicaltrials:NCT00028496]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
eligibility for clinicaltrials:NCT00080938 [clinicaltrials_resource:5788e7b760f448292bcef72966180aed]eligibility for clinicaltrials:NCT00287911 [clinicaltrials_resource:5c09861580e1673edbab9f575b5cc84b]eligibility for clinicaltrials:NCT00430144 [clinicaltrials_resource:7ad91e25693842314381396abe7badb4]eligibility for clinicaltrials:NCT01041404 [clinicaltrials_resource:935a5fc1c7e9a16cd43bb06ab2f4770a]eligibility for clinicaltrials:NCT00004859 [clinicaltrials_resource:93776aab71e2a2eb33df29a2c526dd6f]eligibility for clinicaltrials:NCT00281827 [clinicaltrials_resource:97adf184806d763f343ef52e1ed4ae4d]eligibility for clinicaltrials:NCT01371695 [clinicaltrials_resource:97ca04273a72ac5045fd526a02b16389]
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
eligibility for clinicaltrials:NCT00039442 [clinicaltrials_resource:55bafeba579ec1de90eb7fa6fac780f9]eligibility for clinicaltrials:NCT00080938 [clinicaltrials_resource:5788e7b760f448292bcef72966180aed]eligibility for clinicaltrials:NCT00287911 [clinicaltrials_resource:5c09861580e1673edbab9f575b5cc84b]eligibility for clinicaltrials:NCT00430144 [clinicaltrials_resource:7ad91e25693842314381396abe7badb4]eligibility for clinicaltrials:NCT01041404 [clinicaltrials_resource:935a5fc1c7e9a16cd43bb06ab2f4770a]eligibility for clinicaltrials:NCT00004859 [clinicaltrials_resource:93776aab71e2a2eb33df29a2c526dd6f]eligibility for clinicaltrials:NCT00281827 [clinicaltrials_resource:97adf184806d763f343ef52e1ed4ae4d]eligibility for clinicaltrials:NCT01371695 [clinicaltrials_resource:97ca04273a72ac5045fd526a02b16389]eligibility for clinicaltrials:NCT00070317 [clinicaltrials_resource:bbb37a1cd58c3fe37fc91634b6e762b0]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
Adenocarcinoma [clinicaltrials_resource:ea5fef550a910a2c60d30916913b5c31]
Bio2RDF identifier
ea5fef550a910a2c60d30916913b5c31
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:ea5fef550a910a2c60d30916913b5c31
identifier
clinicaltrials_resource:ea5fef550a910a2c60d30916913b5c31
title
Adenocarcinoma
@en
type
label
Adenocarcinoma [clinicaltrials_resource:ea5fef550a910a2c60d30916913b5c31]
@en
Adenocarcinoma